Traphaco JSC
VN:TRA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Traphaco JSC
Traphaco JSC engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Hanoi, Hanoi and currently employs 1,476 full-time employees. The company went IPO on 2008-11-26. The firm manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. The company is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Traphaco JSC engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Hanoi, Hanoi and currently employs 1,476 full-time employees. The company went IPO on 2008-11-26. The firm manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. The company is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
